EnGene Holdings Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About EnGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy EnGene Holdings Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for EnGene Holdings Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for EnGene Holdings Inc. is ENGN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
EnGene Holdings Inc. has its primary listing on NASDAQ. You can trade EnGene Holdings Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, EnGene Holdings Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include EnGene Holdings Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like EnGene Holdings Inc..